Principal Advisor, Quantum Medicine [ECS and Avantiqor Contract] @ (March 2026 - July 2026)
Senior Innovation Strategy and Management Advisor [ECS and Avantiqor Contract] @ (September 2024 - March 2026)
Chief Scientific Officer and Head of Research Strategy and Alliances @ (August 2023 - August 2024)
Director, Department of Scientific Affairs @ (February 2020 - August 2023)
Program Director, National Center for Advancing Translational Sciences (NCATS) @ (February 2017 - February 2020)
Policy Analyst - Technology Transfer and Innovation Policy, NIH Office of the Director (on detail) @ (December 2016 - May 2017)
Small Business Innovation Specialist (Contract), NIAID @ (August 2014 - December 2016)
Science and Technology Policy Fellow and U.S. Department of State Embassy Science Fellow @ (January 2012 - January 2014)
Principal Advisor, Quantum Medicine [ECS and Avantiqor Contract] @ (March 2026 - August 2026)
Postdoctoral Scientist @ (January 2010 - January 2012)
Principal Advisor, Quantum Medicine [Avantiqor FTE] @ (March 2026 - July 2026)
Senior Innovation Strategy and Management Advisor [Avantiqor FTE] @ (September 2024 - March 2026)
Chief Scientific Officer and Head of Research Strategy and Alliances @ Solve ME/CFS Initiative, Inc. (August 2023 - September 2024)
H. Hsiao Education
Imperial College London
MSc (Biochemical Research / British Chevening Scholar)
Yale University
Ph.D. (Molecular Biophysics & Biochemistry / Anna Fuller Fellow)
NCHU Taiwan
BSc
H. Hsiao Skills
Wildlife
Program Development
Genetic Engineering
Small Business
Seed
Diffusion
Entrepreneurship
Workshops
Business Services
Sourcing
Humanitarian
London
Cluster Analysis
Healthcare
American
Sbir
Foundation
New Initiatives
Academia
Competition
Policy
Market
Technological Solutions
SAN
Science
Strategy
Innovation Management
Biochemistry
Coordinated
Technology Policy
Project Management
Crop
Offerings
Crime
Pricing
Cell
Intellectual Property
Allergy
Pools
Boston
Precise
Ecosystem
Security Clearance
Catalog Development
Technology Commercialization
Citizenship
Biotechnology
Flat Patterning
Biophysics
Technology Transfer
Plant Pathology
Military
Airborne
Tests
Project
Investments
Taiwan
Cancer
Infectious Diseases
Epi
Secret
Metrics
Databases
Usaid
Advancement
Negotiation
Licensing
Innovation Research
Value Creation
Data Profiling
IEEE
Molecular
Missions
Screening
Analysis
Falls Church
Autonomous
Start Ups
Institutes
Mexico
Nih
Pharmaceutics
Customer Service
Integration
Patents
Leadership
Applications
Publications
RFP
Commercial Real Estate
Conferences
Task Force
Mergers and Acquisitions
Start Up Ventures
Invention
Piloting
Research
Council
Management
Patent Applications
Business Intelligence
Business Alliances
Proposal Writing
Author
Program Evaluation
Portfolio
H. Hsiao Summary
H. Hsiao, based in Washington, DC, US, is currently a Chief Scientific Officer at Association for Diagnostics & Laboratory Medicine. H. Hsiao brings experience from previous roles at American Society of Clinical Oncology (ASCO), Advanced Research Projects Agency for Health (ARPA-H) and Solve ME/CFS Initiative. H. Hsiao holds a MSc in Biochemical Research / British Chevening Scholar @ Imperial College London. With a robust skill set that includes Wildlife, Program Development, Genetic Engineering, Small Business, Seed and more. H. Hsiao has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different H. Hsiao?
Find contact details for 700 million professionals.